Personalized Mammography Screening and Screening Adherence-A Simulation and Economic Evaluation

被引:5
作者
Arnold, Matthias [1 ,2 ]
Quante, Anne S. [3 ,4 ,5 ]
机构
[1] Ludwig Maximilians Univ Munchen, Munich Ctr Hlth Sci, Munich, Germany
[2] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Hlth Econ & Hlth Care Management, Neuherberg, Germany
[3] Ludwig Maximilians Univ Munchen, Fac Med, IBE, Chair Genet Epidemiol, Munich, Germany
[4] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Neuherberg, Germany
[5] Tech Univ Munich, Univ Hosp Rechts Isar, Dept Gynecol & Obstet, Munich, Germany
关键词
adherence; breast cancer screening; decision analysis; economic evaluation; mammography; Markov model; personalized medicine; BREAST-CANCER RISK; FAMILY-HISTORY; COST-EFFECTIVENESS; FILM MAMMOGRAPHY; PERCEIVED RISK; WOMEN; BENEFITS; DENSITY; PROGRAMS; DISTRESS;
D O I
10.1016/j.jval.2017.12.022
中图分类号
F [经济];
学科分类号
02 ;
摘要
Objective: Personalized breast cancer screening has so far been economically evaluated under the assumption of full screening adherence. This is the first study to evaluate the effects of nonadherence on the evaluation and selection of personalized screening strategies. Methods: Different adherence scenarios were established on the basis of findings from the literature. A Markov microsimulation model was adapted to evaluate the effects of these adherence scenarios on three different personalized strategies. Results: First, three adherence scenarios describing the relationship between risk and adherence were identified: 1) a positive association between risk and screening adherence, 2) a negative association, or 3) a curvilinear relationship. Second, these three adherence scenarios were evaluated in three personalized strategies. Our results show that it is more the absolute adherence rate than the nature of the risk-adherence relationship that is important to determine which strategy is the most cost-effective. Furthermore, probabilistic sensitivity analyses showed that there are risk-stratified screening strategies that are more cost-effective than routine screening if the willingness-to-pay threshold for screening is below US $60,000. Conclusions: Our results show that "nonadherence" affects the relative performance of screening strategies. Thus, it is necessary to include the true adherence level to evaluate personalized screening strategies and to select the best strategy.
引用
收藏
页码:799 / 808
页数:10
相关论文
共 46 条
  • [1] Breast cancer in European Union: An update of screening programmes as of March 2014 (Review)
    Altobelli, E.
    Lattanzi, A.
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (05) : 1785 - 1792
  • [2] Andersen MR, 2003, CANCER EPIDEM BIOMAR, V12, P314
  • [3] [Anonymous], 2016, AHRQ PUBLICATION
  • [4] Abolishing Mammography Screening Programs? A View from the Swiss Medical Board
    Biller-Andorno, Nikola
    Jueni, Peter
    Kalager, Mette
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (21) : 1965 - 1967
  • [5] Breast Cancer Surveillance Consortium (BCSC), 2016, RISK FACT DAT
  • [6] Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008
  • [7] Categorizing breast mammographic density: intra- and interobserver reproducibility of BI-RADS density categories
    Ciatto, S
    Houssami, N
    Apruzzese, A
    Bassetti, E
    Brancato, B
    Carozzi, F
    Catarzi, S
    Lamberini, MP
    Marcelli, G
    Pellizzoni, R
    Pesce, B
    Risso, G
    Russo, F
    Scorsolini, A
    [J]. BREAST, 2005, 14 (04) : 269 - 275
  • [8] Personalised risk communication for informed decision making about taking screening tests
    Edwards, Adrian G. K.
    Naik, Gurudutt
    Ahmed, Harry
    Elwyn, Glyn J.
    Pickles, Timothy
    Hood, Kerry
    Playle, Rebecca
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (02): : 1 - 96
  • [9] Overdiagnosis of Breast Cancer at Screening is Clinically Insignificant
    Feig, Stephen A.
    [J]. ACADEMIC RADIOLOGY, 2015, 22 (08) : 961 - 966
  • [10] Mammographic screening programmes in Europe: organization, coverage and participation
    Giordano, Livia
    von Karsa, Lawrence
    Tomatis, Mariano
    Majek, Ondrej
    de Wolf, Chris
    Lancucki, Lesz
    Hofvind, Solveig
    Nystrom, Lennarth
    Segnan, Nereo
    Ponti, Antonio
    [J]. JOURNAL OF MEDICAL SCREENING, 2012, 19 : 72 - 82